Status:
UNKNOWN
Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General Anesthesia
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Chronic Kidney Diseases
General Anesthesia
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
Brief Summary
Acute kidney injury (AKI) is one of the most serious and frequent complication of general anesthesia. Patients suffer from chronic kidney diseases (CKD) predispose to develop AKI. CKD patients often n...
Eligibility Criteria
Inclusion
- patients suffering from chronic kidney disease that should undergo surgical interventions under general anesthesia
Exclusion
- pregnancy
- single kidney
- heart failure (NYHA class III-IV)
- hepatic failure
- mental diseases
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
End Date :
January 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01251029
Start Date
January 1 2011
End Date
January 1 2014
Last Update
December 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf Harofeh Medical Center
Ẕerifin, Israel, 70300